# Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures

> **NCT01690221** · PHASE3 · COMPLETED · sponsor: **Ventrus Biosciences, Inc** · enrollment: 434 (actual)

## Conditions studied

- Chronic Anal Fissures

## Interventions

- **DRUG:** VEN 307
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01690221
- **Lead sponsor:** Ventrus Biosciences, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-12
- **Final completion:** 2014-01
- **Target enrollment:** 434 (ACTUAL)
- **Last updated:** 2014-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01690221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01690221, "Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01690221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*